Caris Life Sciences, Inc. (CAI)
19.53
-1.32
(-6.33%)
USD |
NASDAQ |
Feb 20, 16:00
19.52
-0.01
(-0.05%)
After-Hours: 20:00
Caris Life Sciences Shareholders Equity (Quarterly) : 478.36M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 3.253B |
| Glaukos Corp. | 656.16M |
| Edgewise Therapeutics, Inc. | 558.65M |
| Nuvalent, Inc. | 845.40M |
| Alphatec Holdings, Inc. | 35.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 984.57M |
| Total Liabilities (Quarterly) | 506.21M |
| Debt to Equity Ratio | 0.8921 |
| Current Ratio | 9.930 |
| Net Debt Paydown Yield | -1.00% |